Rafael pharmaceuticals announces first patient enrolled in apollo 613 phase 1/2 clinical trial of cpi-613® (devimistat) in patients with relapsed clear cell sarcoma

New trial sites open at cleveland clinic children's and university of michigan new trial sites open at cleveland clinic children's and university of michigan

RFL Ratings Summary

RFL Quant Ranking